Acknowledgements
The authors would like to thank the patients, caregivers, and advocates who participated in this study. The authors also thank Tyron McClain and the Acute Leukemia Advocates Network (ALAN) for their support with this initiative and System Analytic for providing technical support. This study was sponsored by Pfizer. Medical writing and editorial support were provided by Simon Stones, PhD, of Engage Scientific Solutions, and was funded by Pfizer.
Acknowledgements
The authors thank Alex Felicvias and Tom Powles for participating in the podcast. This podcast was sponsored by Pfizer. Medical writing support was provided by Susan Tan, PhD, of Envision Pharma Group, and was funded by Pfizer.
Note
*Oral Presentation
Acknowledgements
We would like to thank Paul Tisdale and Jane Francis for providing English language editing and review services. We would like to thank Tom Crighton and Nathalie Reichmann for performing data checks.
Acknowledgements
We thank Shama Buch of Cactus Life Sciences, Cactus Communications, Mumbai, India, for assisting the initial stage of this project and Madhuri Sankaranarayanan, Vanshika Sahni and Vaibhavi Pardeshi of Cactus Life Sciences, Cactus Communications, Mumbai, India, for their administrative support.
Acknowledgments
Editorial support was provided by Sherri Damlo, ELS, OPEN Health, Parsippany, NJ, USA.
Acknowledgements
Editorial support was provided by Velissaria Vanna (Oxford PharmaGenesis). This study was funded by Open Pharma.
Acknowledgements
We thank Maarten Beekman (Medical Impact+, South Holland, The Netherlands), Leigh M. Boehmer (Association of Community Cancer Center, Rockville, MD, USA), Lily Chu (International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis, Burlingame, CA, USA), and Jessica (Byam) Klein (Ipsen, Boston, MA, USA) for their inputs on the survey questionnaire.
Acknowledgement
Editorial support was provided by Emily Kelly and Christy Vitale of Parexel International, Hackensack, NJ, USA